Efficiency of Monitoring and Control Program of Hypertension Through Pharmacy Offices. APOF Project

NCT ID: NCT02032472

Last Updated: 2014-01-10

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 677 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2010-01-31
• Study Completion Date: 2012-12-31

Brief Summary

Background: Hypertension in adults is the factor most prevalent cardiovascular risk and motivates further inquiries, generating a very high cost of medical care.

Objective: To evaluate the monitoring of well-controlled hypertensive patients Pharmacy Offices. Hypothesis: the monitoring of these patients through the Office of Pharmacy will be as effective in obtaining good control of blood pressure as it is to obtained through health centers. Design: Multicenter randomized controlled trial along one year of follow up. Location: the city of Cerdanyola del Vallès (Barcelona). Participants: All patients diagnosed with hypertension and good control criteria in the past year. Arms: Health centers (control) and Pharmacy Offices (intervention). Outcome variable: blood pressure under good control along the monitoring

Conditions

Hypertension

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: HEALTH_SERVICES_RESEARCH
• Blinding Strategy: NONE

Study Groups

Health Center (usual practice)

Controlling arterial pressure in the health center (a common practice is carried out)

Group Type: NO_INTERVENTION

No interventions assigned to this group

Collaboration of pharmacies

Pharmacies cooperate in Measurement of Arterial Pressure of patients

Group Type: EXPERIMENTAL

Measurement of Arterial Pressure

Intervention Type: OTHER

Pharmacies cooperate in measuring blood pressure of patients

Interventions

Measurement of Arterial Pressure

Pharmacies cooperate in measuring blood pressure of patients

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Age not less than 18 years
• HTA controlled over 2 years of evolution
• Subjects with a history open to participating health centers or stable residence in the geographic area
• Subjects who agree to participate

Exclusion Criteria

• Comorbidity and concomitant (Diabetes Mellitus, Heart failure or renal failure
• Patients with temporary residence in the geographic area of study
• Subjects of hypertension controlled by outside professionals to our primary care teams.
• Subjects with home care or any other cause which does not permit their displacement, transfer to the clinic or pharmacy during the evaluation period.
• Subjects with severe diseases of poor prognosis, hopefully less than one year of life.
• Subjects who do not have telephones.
• Subjects with communication problems (cognitive impairment, sensory, language barrier)

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Institut Catala de Salut

OTHER_GOV

Sponsor Role: collaborator

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Oscar Solans, G Physician

Role: PRINCIPAL_INVESTIGATOR

Institut Català de la Salut (Spain)

Locations

Institut Català de la Salut (ICS)

Cerdanyola Del Valllés, Barcelona, Spain

Countries

Spain

Other Identifiers

APOF_IDIAP

Identifier Type: -

Identifier Source: org_study_id